06087325 is referenced by 52 patents and cites 3 patents.

Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e.g., tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.

Title
Peptide-lipid conjugates
Application Number
8/950618
Publication Number
6087325
Application Date
October 15, 1997
Publication Date
July 11, 2000
Inventor
Donna Cabral Lilly
Lawrenceville
NJ, US
Ravi K Erukulla
Plainsboro
NJ, US
J Craig Franklin
East Windsor
NJ, US
Andrew Janoff
Yardley
PA, US
Shaukat Ali
Monmouth Junction
NJ, US
Charles Pak
Plainsboro
NJ, US
Paul R Meers
Princeton Junction
NJ, US
Agent
Rosanne Goodman
Assignee
The Liposome Company
NJ, US
IPC
C07K 7/00
C07K 5/00
A61K 9/127
A61K 38/00
View Original Source